|
Antibiotic inhibits cancer gene activity (EurekAlert!)
A little-known antibiotic shows early promise as an anti-cancer agent, inhibiting a gene found at higher-than-normal levels in most human tumors, according to researchers at the University of Illinois at Chicago College of Medicine.
(Oct 1, 2006)
Antibiotic Inhibits Cancer Gene Activity (Newswise)
A little-known antibiotic shows early promise as an anti-cancer agent, inhibiting a gene found at higher-than-normal levels in most human tumors.
(Oct 1, 2006)
IU, Purdue Scientists Selected For Major National Cancer Institute Initiative (Medical News Today)
The National Institutes of Health's National Cancer Institute (USA) has selected a team of scientists from Indiana and Purdue universities to assess and develop the next generation of tools to improve biomarker discovery. Such biomarkers should lead to better prevention, diagnosis and treatment of cancer. [click link for full article]
(Oct 1, 2006)
AACR CEO Margaret Foti Receives Cancer Service Award (Medical News Today)
American Association for Cancer Research Chief Executive Officer Margaret Foti, Ph.D., M.D. (h.c.) will receive the Association of American Cancer Institutes (AACI) Distinguished Service Award for her outstanding contributions to progress in cancer research. The award will be presented during a special ceremony at the AACI's annual meeting, October 22 - 24, 2006. [click link for full article]
(Oct 1, 2006)
Around Indiana (Louisville Courier-Journal)
Mayor James Garner has appointed Tim Deatrick, a part-time researcher and student at Indiana University Southeast, as the final member of the city's new Stormwater Board.
(Oct 1, 2006)
3-D Brain Atlas To Help Unlock Mysteries Of Neurological Disorders (Science Daily)
The Allen Institute for Brain Science has announced the completion of the groundbreaking Allen Brain Atlas, a Web-based, three-dimensional map of gene expression in the mouse brain. Detailing more than 21,000 genes at the cellular level, the Atlas provides scientists with a level of data previously not available.
(Oct 1, 2006)
How Fast Does Dark Matter Fall? (Science Daily)
Dark matter is mysterious stuff. Scientists don't really know much about it at all, other than the fact that there seems to be a lot of it in the universe. Thanks to a new analysis by physicists at Caltech and the University of Toronto, we can expect that lumps of dark matter gravitationally attract each other in just the same way that lumps of normal matter (like you and the earth, for instance)
(Oct 1, 2006)
Stock Offerings This Week (New York Times)
The following equity and convertible debt offerings are expected this week:.
(Oct 2, 2006)
Relationship Targets Significant Expansion of QIAGEN's Portfolio of Molecular Tests for Infectious Diseases in the (CNW Group via Yahoo! Finance)
QIAGEN N.V. , a leading provider of molecular diagnostics products and the world's premier supplier of solutions for preanalytical sample preparation, today announced that it has entered a strategic agreement with the British Veterinary Laboratories Agency , one of the world's leading laboratories in the field of veterinary testing.
(Oct 2, 2006)
Berkeley Lab Life Scientists Are Leaders In Team To Detect Cancer By Studying Proteins In The Blood (Medical News Today)
The National Cancer Institute (NCI) today announced awards totaling over $35.5 million to establish a network of teams that will investigate how to detect cancer by finding cancer-specific proteins and protein patterns in blood samples. [click link for full article]
(Oct 2, 2006)
GNI Group Sees Demand for Synthetic Bone Material Product in China (Business Wire via Yahoo! Finance)
TOKYO----GNI Ltd, a leading biopharmaceutical company in Asia, has announced that its China based affiliate Shanghai Genomics has expanded sales of Gu-Bang, a new type of synthetic bone biomaterial, after winning several hospital supply contracts in Beijing, Shanghai and Guandong province.
(Oct 2, 2006)
Bio-IT Briefs (Bio-IT World)
October 02, 2006 | Millennium Pharmaceuticals Inc . has entered into an agreement to acquire AnorMED Inc ., a Canada-based biopharmaceutical company with a late-stage Phase III hematology-oncology product, Mozobil.
(Oct 2, 2006)
GNI Group Sees Demand for Synthetic Bone Material Product in China (RedNova)
GNI Ltd, a leading biopharmaceutical company in Asia, has announced that its China based affiliate Shanghai Genomics has expanded sales of Gu-BangTM, a new type of synthetic bone biomaterial, after winning several hospital supply contracts in Beijing, Shanghai and Guandong province.
(Oct 2, 2006)
Acacia Technologies Licenses Resource Scheduling Technology to 3M Company (Business Wire via Yahoo! Finance)
NEWPORT BEACH, Calif.----Acacia Research Corporation announced today that Resource Scheduling Corporation, a wholly owned subsidiary that is part of the Acacia Technologies group, a leader in technology licensing, has entered into a license with 3M Company covering a patent that applies to systems for scheduling and managing resources.
(Oct 2, 2006)
TECHWORKING (Washington Post)
LCG Systems plans to hire about five people in the next month and a half. Howard Stern, vice president of business development, talked with The Post's Judith Mbuya.
(Oct 2, 2006)
Acacia Technologies Licenses Resource Scheduling Technology to 3M Company (Broadcast Newsroom)
NEWPORT BEACH, Calif.,
(Oct 2, 2006)
Acacia Technologies Licenses Multi-Dimensional Bar Code Technology to Allstate Insurance Company (Broadcast Newsroom)
NEWPORT BEACH, Calif.,
(Oct 2, 2006)
Acacia Technologies Licenses Multi-Dimensional Bar Code Technology to Texas Instruments (Broadcast Newsroom)
NEWPORT BEACH, Calif.,
(Oct 2, 2006)
QIAGEN and VLA Enter Into Agreement in Veterinary Testing (SYS-CON Media)
QIAGEN N.V. (NASDAQ: QGEN)(Frankfurt, Prime Standard: QIA), a leading provider of moleculardiagnostics products and the world's premier supplier of solutions forpreanalytical sample preparation, today announced that it has entered astrategic agreement with the British Veterinary Laboratories Agency (VLA),one of the world's leading laboratories in the field of veterinary testing.
(Oct 2, 2006)
InnovationWell Discusses Innovation in Life Science & Healthcare Research & Product Development (PR Web via Yahoo! News)
Zeiningen, Switzerland (PRWEB) October 2, 2006 -- The InnovationWell Community of Practice InterAction Meeting "Innovation in Life Science & Healthcare Research & Product Development" will take place 16-19 October 2006, Bryn Mawr College, Philadelphia, USA.
(Oct 2, 2006)
QIAGEN and VLA Enter Into Agreement in Veterinary Testing (SYS-CON Media)
QIAGEN N.V. (NASDAQ: QGEN)(Frankfurt, Prime Standard: QIA), a leading provider of moleculardiagnostics products and the world's premier supplier of solutions forpreanalytical sample preparation, today announced that it has entered astrategic agreement with the British Veterinary Laboratories Agency (VLA),one of the world's leading laboratories in the field of veterinary testing.
(Oct 2, 2006)
Genetic 'Roadmap' Charts Links Between Drugs And Human Disease (Science Daily)
A research team led by scientists at the Broad Institute of MIT and Harvard developed a new kind of genetic "roadmap" that can connect human diseases with potential drugs to treat them, as well as predict how new drugs work in human cells. Called the "Connectivity Map," the tool and its uses are described in the September 29 issue of Science and in separate publications in the September 28
(Oct 2, 2006)
Cloned Mice Created From Fully Differentiated Cells, A Milestone In Cloning Research (Science Daily)
New research dismisses the notion that adult stem cells are necessary for successful animal cloning, proving instead that cells that have completely evolved to a specific type not only can be used for cloning purposes, but they may be better and more efficient. As proof, researchers report they created two mouse pups from a type of blood cell that itself is incapable of dividing to produce a
(Oct 2, 2006)
Gene Key To Taste Bud Development Identified (Science Daily)
Scientists have identified a gene that controls the development of taste buds. The gene, SOX2, stimulates stem cells on the surface of the embryonic tongue and in the back of the mouth to transform into taste buds, according to the researchers. Stem cells are immature cells that can develop into several different cell types depending on what biochemical instructions they receive.
(Oct 2, 2006)
Antibiotic Inhibits Cancer Gene Activity (Science Daily)
A little-known antibiotic shows early promise as an anti-cancer agent, inhibiting a gene found at higher-than-normal levels in most human tumors, according to researchers at the University of Illinois at Chicago College of Medicine.
(Oct 2, 2006)
Clintons have a blast watching Bills at stadium (The Buffalo News)
Yes, that was Sen. Hillary Rodham Clinton and her husband, the former president, cheering during the Buffalo Bills' victory Sunday afternoon at Ralph Wilson Stadium.
(Oct 2, 2006)
Major Cancer Study Aims To Identify Protein Markers For Early-stage Disease (Medical News Today)
A team led by Bay Area scientists is one of five nationwide to receive a major grant from the National Cancer Institute (NCI) to refine and standardize the technologies for identifying biomarkers in the blood -- specific proteins, and the patterns they make -- for the early detection of cancer. [click link for full article]
(Oct 2, 2006)
Tsakos Names Aristides Patrinos to Board (AP via Yahoo! Finance)
Greek oil shipper Tsakos Energy Navigation Ltd. on Monday said its has named Aristides A. N. Patrinos to the board. Patrinos is president of Synthetic Genomics, a company developing synthetic biology advances in the energy field.
(Oct 2, 2006)
Tsakos names Aristides Patrinos to board (Sharewatch)
Patrinos is president of Synthetic Genomics, a company developing synthetic biology advances in the energy field. He previously worked for the Energy Department\'s Office of Science, where he was director of the Office of Biological and Environmental Research.
(Oct 2, 2006)
Molecular atlas provides new tool for understanding estrogen-fueled breast cancer (EurekAlert!)
BOSTON -- Lurking in unexplored regions of the human genome are thousands of previously unknown on/off switches that may influence how the growth of breast cancer is driven by estrogen, new research by Dana-Farber Cancer Institute researchers has revealed.
(Oct 2, 2006)
Ex-QB Kelly on receiving end of federal aid (Business First of Buffalo)
Before Sen. Hillary Rodham Clinton attended Sunday's Buffalo Bills home game, she scored a touchdown with the team's Hall of Fame quarterback, Jim Kelly.
(Oct 2, 2006)
Special Delivery from Remote-Controlled Nanocarriers (Medical Device Link)
Work has been done on developing drug-filled nanocarriers via a magnetic field, but a more concentrated approach to targeting tumors, which could reduce side effects, may be needed. Research at the State University of New York (SUNY) in Buffalo shows promise.
(Oct 2, 2006)
Mistral Pharma to Present at BioContact 2006 (Market Wire via Yahoo! Finance)
Mistral Pharma Inc. announced today that it will be a presenter at the BIOCONTACT 2006 conference at the Chateau Frontenac in Quebec city. This presentation will be given by Mr. Bertrand Bolduc, President and Chief Executive Officer of Mistral Pharma, on October 6, 2006 in the Bellevue room at 10 a.m.
(Oct 2, 2006)
Mistral Pharma to Present at BioContact 2006 (CCNMatthews via Yahoo! Finance)
MONTREAL, QUEBEC-- - Mistral Pharma Inc. announced today that it will be a presenter at the BIOCONTACT 2006 conference at the Chateau Frontenac in Quebec city. This presentation will be given by Mr.
(Oct 2, 2006)
Springer's Journal Of Robotic Surgery Positioned To Become Leading Resource For Robotic Techniques In Surgery (Medical News Today)
Springer, one of the world's leading science, technology, and medicine publishers, is launching the Journal of Robotic Surgery. This new journal will be the first to focus exclusively on emerging robotic applications in surgery, and is positioned to become the world's foremost clinical resource for robotic surgical education. Four issues will be published annually, starting January 2007. [click
(Oct 2, 2006)
Dr. Tim Tingkang Xia to be Guest Speaker At World Renowned China Hi-Tech Fair (PrimeZone via Yahoo! Finance)
Tim Tingkang Xia, Ph. D., a partner in the Intellectual Property Practice and International Practice at Morris Manning & Martin LLP, has been invited to speak at the 2006 China Hi-Tech Fair, held at the Shenzhen Convention and Exhibition Center in China on October 14, 2006.
(Oct 2, 2006)
Molecular Atlas Provides New Tool for Understanding Estrogen-fueled Breast Cancer (Newswise)
Dana-Farber investigators have developed the first complete map of the molecular "control panels" operated by the cells' estrogen receptor, the master regulator of cell growth in the most common form of breast cancer. This may eventually help doctors match patients with treatments that are most likely to be effective and overcome the problem of resistance to current hormone therapies.
(Oct 2, 2006)
Yale Tomorrow Campaign Establishes $3 Billion Goal (Yale University)
New Haven, Conn. — The University has launched a five-year, $3 billion “ Yale Tomorrow ” campaign to expand its capacity to contribute to a global society through its scholarship and graduates.
(Oct 2, 2006)
'Gene Silencing' Discoverers Win Nobel Prize (Science Daily)
The Prize in Physiology or Medicine for 2006 has been awarded jointly to Andrew Z. Fire and Craig C. Mello for their discovery of "RNA interference -- gene silencing by double-stranded RNA" -- a fundamental mechanism for controlling the flow of genetic information.
(Oct 2, 2006)
Mistral Pharma to Present at BioContact 2006 (SYS-CON Media)
Mistral Pharma Inc. (TSX VENTURE: MIP) announced today that it will be a presenter at the BIOCONTACT 2006 conference at the Chateau Frontenac in Quebec city. This presentation will be given by Mr. Bertrand Bolduc, President and Chief Executive Officer of Mistral Pharma, on October 6, 2006 in the Bellevue room at 10 a.m.
(Oct 2, 2006)
Sorenson branches out to forensics (The Salt Lake Tribune)
Posted: 3:58 PM- Sorenson Genomics hopes to expand on its worldwide renown for DNA-testing expertise with launch of a biological forensics division. Sorenson Forensics plans to be a helping-hand-for-hire to federal, state and metropolitan crime laboratories as well as trial attorneys. The division will also take on missing persons and private industry work, said Doug Fogg, chief
(Oct 2, 2006)
ATI Will Tune Its Graphics Chips For High-Performance Apps (InformationWeek)
The plan by ATI, which is set to merge with chip maker Advanced Micro Devices this month, could give AMD a competitive edge against Intel in the fast-growing market for high-performance computing.
(Oct 2, 2006)
Surveys shape museum exhibits on science (AP via Yahoo! News)
When the results of its latest survey came back, officials at the American Museum of Natural History were hardly astonished.
(Oct 2, 2006)
Massively Parallel Trims, Refuses (RedNova)
By Matt Branaugh, Daily Camera, Boulder, Colo. Sep.
(Oct 3, 2006)
IU, Purdue Selected For Major NCI Biomarker Tools Initiative (Medical News Today)
The National Institutes of Health's National Cancer Institute has selected a team of scientists from Indiana and Purdue universities to assess and develop the next generation of tools to improve biomarker discovery. Such biomarkers should lead to better prevention, diagnosis and treatment of cancer. [click link for full article]
(Oct 3, 2006)
Children's, UPMC get $12.8 million grant for lung disease research (Pittsburgh Post-Gazette)
Pulmonary researchers at Children's Hospital and the University of Pittsburgh School of Medicine have received a $12.8 million federal grant to study how individual differences influence the development of certain lung conditions.
(Oct 3, 2006)
New branch reaches into full-blown forensics (The Salt Lake Tribune)
Sorenson Genomics hopes to expand on its worldwide renown for DNA-testing expertise with today's launch of a biological forensics division. Sorenson Forensics plans to be a helping-hand-for-hire to federal, state and metropolitan crime laboratories, as well as trial attorneys. The division also will take on missing persons and private industry work, said Doug Fogg, chief operating officer for
(Oct 3, 2006)
No clue is too small for lab (Deseret Morning News)
The evidence seems innocent enough a shirt, a sock, a pair of shoes. But a closer look reveals a darker secret saliva, semen, a blood stain. At Sorenson Forensics, a team of nine people is now dedicating its efforts to solving society's worst crimes.
(Oct 3, 2006)
How to become a bio-informaticist (Independent Online)
This is a job for people who are fascinated by biology and technology, and are not afraid of mathematics.
(Oct 3, 2006)
Sorenson Genomics Launches New Advanced Sorenson Forensics Division (Business Wire via Yahoo! Finance)
SALT LAKE CITY & SAN FRANCISCO----Sorenson Genomics, a leading global provider of DNA-related testing services, announced today at the 2006 American Society of Crime Laboratory Directors Symposium that it has expanded its core business offering with the addition of an advanced forensics division.
(Oct 3, 2006)
|
